Kymera Therapeutics Insider Sold Shares Worth $5,950,000, According to a Recent SEC Filing
Nello Mainolfi, Director, Chief Executive Officer, on July 07, 2026, sold 50,000 shares in Kymera Therapeutics (KYMR) for $5,950,000. Following the Form 4 filing with the SEC, Mainolfi has control over a total of 666,568 common shares of the company, with 666,568 shares held directly. SEC Filing:
Nello Mainolfi, Director, Chief Executive Officer, on July 07, 2026, sold 50,000 shares in Kymera Therapeutics (KYMR) for $5,950,000.
Following the Form 4 filing with the SEC, Mainolfi has control over a total of 666,568 common shares of the company, with 666,568 shares held directly.
SEC Filing: